Vaxcyte price target raised to $153 at Leerink after VAX-31 ‘home run’
PremiumThe FlyVaxcyte price target raised to $153 at Leerink after VAX-31 ‘home run’
22d ago
Needham ups Vaxcyte target to $140 after ‘best-case scenario’ data
Premium
The Fly
Needham ups Vaxcyte target to $140 after ‘best-case scenario’ data
22d ago
Vaxcyte price target raised to $140 from $95 at Needham
Premium
The Fly
Vaxcyte price target raised to $140 from $95 at Needham
22d ago
Vaxcyte reports data from study of VAX-31 vaccine candidate in adults 50+
PremiumThe FlyVaxcyte reports data from study of VAX-31 vaccine candidate in adults 50+
23d ago
Vaxcyte reports Q2 EPS ($1.10), consensus (98c)
Premium
The Fly
Vaxcyte reports Q2 EPS ($1.10), consensus (98c)
2M ago
Vaxcyte Appoints John Furey as New Independent Board Director
Premium
Company Announcements
Vaxcyte Appoints John Furey as New Independent Board Director
3M ago
Vaxcyte reports Q1 EPS (85c), consensus ($1.17)
PremiumThe FlyVaxcyte reports Q1 EPS (85c), consensus ($1.17)
5M ago
PCVX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PCVX Upcoming Earnings Report: What to Expect?
5M ago
Vaxcyte price target raised to $113 from $69 at Mizuho
Premium
The Fly
Vaxcyte price target raised to $113 from $69 at Mizuho
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100